Clinical Outcome of Prostate Cancer Patients with Germline DNA Repair Mutations: Retrospective Analysis from an International Study. (2018)
Attributed to:
Predictive biomarkers of response to DNA repair targeting agents in sporadic prostate cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.eururo.2018.01.010
PubMed Identifier: 29429804
Publication URI: http://europepmc.org/abstract/MED/29429804
Type: Journal Article/Review
Volume: 73
Parent Publication: European urology
Issue: 5
ISSN: 0302-2838